| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/05/2008 | US20080131396 Using cytokine mixture as localizing tool in tissue target therapy of cell proliferative masses |
| 06/05/2008 | US20080131370 For prophylaxis or treatment of apoptosis or inflammation-associated disease, diabetes, or chronic obstructive pulmonary disease |
| 06/05/2008 | US20080131363 Rs7 antibodies |
| 06/05/2008 | DE102006056604A1 A peptide which correlates with the proteolytic activity of a tumor-suppressor protein, especially retinoblastoma protein or insulin-degrading enzyme, used for the diagnosis and prognosis of diseases, especially cancer |
| 06/05/2008 | DE10107186B4 Neue Form des PHGPx-Proteins als diagnostischer Marker bei männlicher Infertilität A new form of PHGPx protein as a diagnostic marker for male infertility |
| 06/05/2008 | CA2705495A1 Methods of diagnosing and alleviating gadolinium toxicity |
| 06/05/2008 | CA2693178A1 Myostatin inhibition for enhancing muscle and/or improving muscle function |
| 06/05/2008 | CA2673757A1 Poxviridae treatment |
| 06/05/2008 | CA2672936A1 Method for in situ solidification of blood-polymer compositions for regenerative medicine and cartilage repair applications |
| 06/05/2008 | CA2672369A1 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl-d-tryptophan |
| 06/05/2008 | CA2671060A1 Polypeptides having modulatory effects on cells |
| 06/05/2008 | CA2670955A1 Potentiation of erythropoietin (epo) action by membrane steroid receptor agonists |
| 06/05/2008 | CA2670790A1 Polypeptides comprising fas activation and nkg2d-ligand domains |
| 06/05/2008 | CA2670532A1 Metastasis-specific peptides and their diagnostic and therapeutic applications |
| 06/05/2008 | CA2670460A1 Tslp vaccine for the treatment of th2 mediated inflammatory conditions |
| 06/05/2008 | CA2670440A1 Use of beta-lactamase |
| 06/05/2008 | CA2668932A1 Modified soluble fgf receptor fc fusions with improved biological activity |
| 06/05/2008 | CA2666549A1 Il-17a/f heterodimeric polypeptides and therapeutic uses thereof |
| 06/05/2008 | CA2665210A1 S-nitrosothiol compounds and related derivatives |
| 06/04/2008 | EP1927858A1 Conformationally constrained peptides that bind the ORL-1 receptor |
| 06/04/2008 | EP1927665A2 Methods and kits for diagnosing and treating b-Cell chronic lymphocytic leukemia (B-CLL) |
| 06/04/2008 | EP1927660A2 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions |
| 06/04/2008 | EP1927659A1 Wisp polypeptides and therapeutical applications thereof |
| 06/04/2008 | EP1927657A2 Compositions and methods for producing antigen-presenting cells |
| 06/04/2008 | EP1927600A1 Homogeneous preparations of IL-28 and IL-29 |
| 06/04/2008 | EP1927598A1 Vaccine |
| 06/04/2008 | EP1927597A1 Antibacterial peptides |
| 06/04/2008 | EP1927368A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 06/04/2008 | EP1927367A1 Novel pharmaceutical using anti-hla antibody |
| 06/04/2008 | EP1927365A1 A new bacillus subtilis strain and its use in preparing medicine for treating thrombosis |
| 06/04/2008 | EP1927364A1 Polypeptides having modulatory effects on cells |
| 06/04/2008 | EP1927362A2 Alphavbeta3integrin as a predictor of endometriosis |
| 06/04/2008 | EP1926747A1 Mcp1 fusions |
| 06/04/2008 | EP1926743A1 2-(AMINOMETHYL)-5-CHLOROBENZYLAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE CLOTTING FACTOR Xa |
| 06/04/2008 | EP1926495A2 Therapeutic use of outer shigella protein f (os pf) |
| 06/04/2008 | EP1926494A2 Agonistic and antagonistic peptide mimetics of the vegf alpha-helix binding region for use in therapy |
| 06/04/2008 | EP1606633B1 Diagnostics and therapeutics for diseases associated with dopamine receptor d3 (drd3) |
| 06/04/2008 | EP1597589B1 Diagnostics and therapeutics for haematological diseases associated with 5-hydroxytryptamine 1f receptor (5-ht1f) |
| 06/04/2008 | EP1556504B1 Protozoan rhomboid proteins |
| 06/04/2008 | EP1493033B1 Use of sc6 for diagnosis and treatment of breast carcinoma |
| 06/04/2008 | EP1463754B1 Cystine-knot fold protein |
| 06/04/2008 | EP1448089A4 Devices and methods for the restoration of a spinal disc |
| 06/04/2008 | EP1365781B1 Acrochordon alleviation |
| 06/04/2008 | EP1192182B1 Pituitary adenylate cyclase activating peptide (pacap) receptor 3 (r3) agonists and their pharmacological methods of use |
| 06/04/2008 | EP1137436B1 Stimulation of T-cells against self antigens using CTLA-4 blocking agents |
| 06/04/2008 | EP1028749B1 Enterococcus antigens and vaccines |
| 06/04/2008 | EP1019082B2 Use of a colony stimulating factor (csf) for enhancing collateral growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 06/04/2008 | EP0990703B1 Novel polypeptide, dna encoding the same and use thereof |
| 06/04/2008 | EP0958305B1 Inhibitions of the interaction between p53 and mdm2 |
| 06/04/2008 | EP0946199B1 TGF beta 1-RESPONSIVE CELLS FROM BONE MARROW |
| 06/04/2008 | EP0920505B1 Mammalian cell surface antigens; related reagents |
| 06/04/2008 | EP0672143B1 Lymphotoxin-beta, lymphotoxin-beta complexes, pharmaceutical preparations and therapeutic uses thereof |
| 06/04/2008 | CN101194017A Conjugate comprising p21 protein for the treatment of cancer |
| 06/04/2008 | CN101193908A Organic compounds |
| 06/04/2008 | CN101193657A Endoparasiticide |
| 06/04/2008 | CN101193652A Pharmaceutical formulations comprising incretin peptide and aprotic polar solvent |
| 06/04/2008 | CN101193651A Mannan-binding lectin (MBL) in the treatment of immunocompromised conditions asssociated with cancer |
| 06/04/2008 | CN101193650A Abuse-resistant amphetamine prodrugs |
| 06/04/2008 | CN101191130A ChIFNGR1 gene and its coding protein and application |
| 06/04/2008 | CN101191129A Gene engineering domestic silkworm antibiotic peptide and its preparation method and application |
| 06/04/2008 | CN101190946A Recombination plasmodium falciparum circumsporozoite surface protein and its preparation method and use |
| 06/04/2008 | CN101190945A Preparation for specificity anticoagulant substance and application thereof |
| 06/04/2008 | CN101190943A Jiangzhe snake venom double-chain peptide, preparation method and application thereof |
| 06/04/2008 | CN101190942A Compound with thrombus dissolving activity and its preparation method and application |
| 06/04/2008 | CN101190941A Polypeptide with thrombus dissolving activity and its preparation method and application |
| 06/04/2008 | CN101190940A Polypeptide with target antithrombotic activity and its preparation method and application |
| 06/04/2008 | CN101190939A Oligopeptide-copper complex with blood vessel extending and thrombus dissolving activity and its preparation method and application |
| 06/04/2008 | CN101190331A Medicinal composition for preventing and treating respiratory tract infection and uses thereof |
| 06/04/2008 | CN101190330A Application of cholinesterase in antagonistic tachykinin medicine |
| 06/04/2008 | CN101190329A Medicinal composition for regrouping human P43 protein and its application in medication |
| 06/04/2008 | CN100392082C Conserved neisserial antigens |
| 06/04/2008 | CN100392080C Variable region of light chain and heavy chain genes of anti-KDR monoclonal antibody and its use |
| 06/04/2008 | CN100392079C Protein C or activated protein C-like molecules |
| 06/04/2008 | CN100392077C Carbohydrate oxidase and use thereof in baking |
| 06/04/2008 | CN100391980C Antitumour multitarget composite antigen, its coding gene and application |
| 06/04/2008 | CN100391978C Recombinant anti-CD4 antibodies for human therapy |
| 06/04/2008 | CN100391977C Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
| 06/04/2008 | CN100391972C Corticotropin releasing factor receptor 2 agonists |
| 06/04/2008 | CN100391970C DNA sequence and recombinant production of the grass pollen allergen Phl p4 |
| 06/04/2008 | CN100391969C Helicobacter Pylori urease B subunit Th epitope peptide, its coding DNA, vaccine and uses |
| 06/04/2008 | CN100391968C Goniothalamicim cyclopeptide B of anti-tumor compound and isomer and its preparing method |
| 06/04/2008 | CN100391967C Hepatitis C tripeptide inhibitors |
| 06/04/2008 | CN100391535C Application of enzymic hemostat in antagonizing hirudin hemorrhage |
| 06/04/2008 | CN100391534C Modulation of smooth muscle cell proliferation |
| 06/04/2008 | CN100391533C Wood louse analgesia peptide, preparation method and application |
| 06/04/2008 | CN100391469C Remedies for hepatitis C |
| 06/04/2008 | CN100391462C Enhanced drug delivery in transdermal systems |
| 06/04/2008 | CN100391445C Novel 'burst-free' sustained release poly-(lactide/glycolide) mi crospheres |
| 06/04/2008 | CN100391432C Skin depigmenting compositions comprising adapalene and at least one depigmenting active agent |
| 06/04/2008 | CN100391354C Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis |
| 06/03/2008 | US7383084 Transdermal delivery system for dried particulate or lyophilized medications |
| 06/03/2008 | US7381805 Compositions comprising mixtures of positional PEG isomers of PEGylated G-CSF |
| 06/03/2008 | US7381804 A colony-stimulating factor hybrid molecules, computer analyzing the three dimensional structure protein, crystallization of the protein |
| 06/03/2008 | US7381803 Humanized antibodies against CD3 |
| 06/03/2008 | US7381800 Antibodies to HBIMF63 polypeptide |
| 06/03/2008 | US7381799 Compositions and methods for inhibiting angiogenesis |
| 06/03/2008 | US7381796 Dried blood factor composition comprising trehalose |
| 06/03/2008 | US7381795 Modified interferon beta with reduced immunogenicity |
| 06/03/2008 | US7381793 Extracellular matrix-binding proteins from Staphylococcus aureus |
| 06/03/2008 | US7381792 soluble, recombinant Receptor Activator of Nuclear Factor kappa B Ligand (RANKL) for drug screening; expressed in Escherichia coli |